Moderna, Inc. - Common Stock · Transaction Sep 24, 2026 · Filed Oct 7, 2026 · $1,001 to $15,000
NASDAQ NMS - GLOBAL MARKET · MRNA
-7.82% · -$18.49 · Vol Not reported
Market closed · last close 4:00 PM ET · price as of 16:00:00 ET
Moderna Inc
Biotechnology
$218.01
Follow $MRNA
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $MRNA by emailVeridion Score
BETAHIGH CONF · 6 of 6 factors measuredFri Oct 16 · last completed session · Markets closed · resumes Mon 9:30 ET · MRNA
MethodologyMRNA
Moderna Inc
Fri Oct 16 · last completed session · Markets closed · resumes Mon 9:30 ET
Highest qualified
Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
82/ 100
Veridion Score
Highest qualified · HIGH confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Confidence: HIGH · 6 of 6 factors measured · Fri Oct 16 · last completed session · Markets closed · resumes Mon 9:30 ET
AI Analysis
SovereignWhy is MRNA moving today?
Sovereign unlock connects news, insider activity, analyst moves, and available price action.
About Moderna Inc
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)Founded
2010
Listed
2018
Employees
5K
Country
US
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 25 mRNA development candidates in clinical studies as of March 2026. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$235.00
Day high
$237.96
Day low
$208.92
Previous close
$236.50
52W high
$237.96
-8.38% from high
52W low
$22.36
91% of range
Market cap
$87B
EPS
$-7.9847
Beta
2.50
Shares out
399.2M
Avg volume
16.4M
VWAP
$236.50
Last session
Price history computed in-house
1W
-3.11%
1M
+41.53%
3M
+266.46%
1Y
+738.18%
YTD
+639.27%
SMA 50 $154.93 · above
SMA 200 $77.40 · above
52W position 91%
MRNA overview
Related filings and maps
Public disclosures
Congress activity in MRNA
6 filers · 7 buys · 17 sells (0 labeled S (partial)) · May 22, 2020 to Sep 24, 2026 · House 24 / Senate 0
All available history · Latest 5 of 24 lines · Read Oct 18, 2026, 5:03 PM UTC
Official filing ↗
Moderna, Inc. - Common Stock · Transaction Apr 8, 2025 · Filed May 8, 2025 · $1,001 to $15,000
Moderna, Inc. - Common Stock · Transaction Feb 1, 2024 · Filed Mar 7, 2024 · $1,001 to $15,000
Moderna, Inc. · Transaction Sep 15, 2023 · Filed Oct 15, 2023 · $1,001 to $15,000
Moderna, Inc. · Transaction Jul 12, 2023 · Filed Aug 13, 2023 · $50,001 to $100,000
Federal contracts
MRNA contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for MRNA in this window.
Lobbying spend
MRNA lobbying filings, year to date.
Registered lobbying filings matched to Moderna Inc.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for MRNA in this window.
Analyst ratings
Sovereign unlock shows available analyst consensus for MRNA.